Replies to post #305 on *DAY TRADING ACADEMY* (ZZMAN)

[zigzagman]

Thanks for the very informative post 'chichi2'...

And Welcome! to the board...

I want to thank you so much for bringing DNDN to my attention the other day...And for posting your thoughts on the next possible runner...I have been watching DSCO for about a week now, but it's one of those stocks that Scottrade won't allow you to buy online...So I'll have to call in a Buy Order to them on the phone...I don't have a problem with that, and I'll take care of that tomorrow because I hear that April 17th is a really big day for DSCO...

I agree with your call to Short the Financials tomorrow...The Dow and S&P 500 closed at the low of the day, and that usually calls for another down day tomorrow...I haven't had time to look at my charts tonight, but I'll post my thoughts after I look at them early in the morning...I also need to check what Economic Reports are coming out, and who's giving Q1 Earnings Reports...

I didn't get ANY sleep last night...I was too excited and a bit apprehensive about what DNDN would do today...I feel very blessed things went well on that trade, and for meeting you and finally acting on your little "tip" on that one...

I look forward to hearing anything you have to say because I have a lot of respect for your abilities and your wealth of knowledge that comes from trading the market for fifty years...Art Cashin is my favorite TV commentator, and I listen to every word he has to say very carefully...

Please feel free to post your thoughts here anytime...When chichi2 talks, we should all pay very close attention...JMVHO

[zigzagman]

DSCO is on the MOVE! again today...

(from your post here yesterday chichi2...Great! call BTW...)

Shares of Discovery Laboratories Inc. (DSCO, $2.15, +$0.16, +8.04%) gained as the biotechnology company announced it has made progress on its capillary aerosolization technology, a system that delivers a mist of drugs deep into the lungs, where they are most effective. Wedbush Morgan also tied the gains to hopes that the FDA will soon give approval for Discovery's lead product, Surfaxin, a treatment to prevent respiratory distress syndrome in premature infants. The FDA, which already has withheld approval for this treatment two times, is expected to release its decision Friday.

[zigzagman]

According to this post from last night...

We were supposed to "Short the Financials"???...hmmmmmm...

FAS Up $1.03 +13.10%

That's why I'm just a Day Trader...

The trend had four major direction changes on the $SPX today...

Long, Short, Long, Short, Lonnnnnng...lol